德希尼布FMC FTI 深 滬
等待開盤 12-09 09:30:00 美东时间
45.33
-0.690
-1.50%
華盛通- 最 高46.195
- 今 開45.73
- 成交量 209.80万股
- 最 低 45.05
- 昨 收 46.02
- 總市值 183.59亿
- 52周最高 47.33
- 市盈率 靜 23.69
- 換手率 0.52%
- 52周最低 21.965
- 委 比 40.43%
- 總股本 4.05亿
- 歷史最高 59.2114
- 量 比 0.80
- 振 幅 2.49%
- 歷史最低 0.9514
- 每 手 1
- 風險率 5.29%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多TechnipFMC wins North Sea flexible pipe contract from Ithaca Energy
TechnipFMC (FTI) said on Monday it received a significant contract from Ithaca Energy to design, manufacture and install flexible risers, flowlines and related hardware for the Captain field in the UK...
今天 05:22
Shares of oil stocks are trading higher amid supply concerns on reports of Iran seizing an oil tanker in the Strait of Hormuz as well as reports of a Ukrainian drone strike on Russia's Novorossiysk port.
Shares of oil stocks are trading higher amid supply concerns on reports of Iran...
11-15 01:10
Oil’s 4.5% tumble isn’t stopping these 2025 energy winners
Crude oil (CL1:COM) extended its recent slide on Wednesday, falling 4.5% amid mounting selling pressures. This weakness is part of a broader trend, with oil prices down 18.9% year-to-date in 2025, ref...
11-13 04:27
Shares of oil-related stocks are trading lower amid a stronger US dollar and concerns about a potential oversupply.
Shares of oil-related stocks are trading lower amid a stronger US dollar and co...
11-05 04:35
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
美股大行评级 | 275美元！美银证券上调英伟达目标价；花旗上调思佳讯评级至"中性"，目标价从66美元升至91美元
今日重点评级关注：HC Wainwright & Co.：维持Unicycive Therapeutics"买入"评级，目标价从9美元升至22美元；花旗：维持Arcus Biosciences"买入"评级，目标价从54美元升至56美元
10-30 14:22
美股大行评级 | 上调！苹果、亚马逊、Amkor Tech、Cadence、Confluent、卡特、通用动力等获多家上调目标价
今日重点评级关注：HC Wainwright & Co.：维持PepGen"买入"评级，目标价从12美元升至18美元；Piper Sandler：维持Prothena Corp"超配"评级，目标价从15美元升至36美元
10-29 09:25
Earnings Outlook For Tenaris
Tenaris (NYSE:TS) is set to give its latest quarterly earnings report on Wednes...
10-29 01:02
美股大行评级 | 买入！Fermi、Neptune获多家大行首予评级；伯克希尔哈撒韦罕见地获得“卖出”评级；摩根大通上调苹果目标价升至290美元
今日重点评级关注：Guggenheim：上调Neumora Therapeutics评级至"买入"，目标价14美元；韦德布什：上调Fate Therapeutics评级至"跑赢大市"，目标价从5美元升至7美元
10-28 10:08
Barclays Maintains Overweight on TechnipFMC, Raises Price Target to $53
Barclays analyst David Anderson maintains TechnipFMC (NYSE:FTI) with a Overweight and raises the price target from $51 to $53.
10-27 23:13
